uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Aqumeldi
Authorised
Human
Details
EMA number
EMEA/H/C/005731
ATC code
C09AA02
Authorisation
15 November 2023
Revision
2
EMA page
Therapeutic indication
Treatment of heart failure.
MeSH:
Heart Failure
Group:
Agents acting on the renin-angiotensin system
Active substances
Enalapril (maleate)
Marketing Authorisation Holder
Proveca Pharma Limited
MAH
Timeline
Filter by authority:
EMA
Aqumeldi authorised
15 Nov 2023
authorised
regulatory
Aqumeldi | uMedical